Risk of HLA antibody generation after receipt of Mirasol versus standard platelets in the MIPLATE randomized trial.

Zhanna KaidarovaClara DiGermanio Brian S Custer Phillip J Norris

Published in: Transfusion (2023)

The data do not support the conclusion that Mirasol exerted a protective effect against alloimmunization after platelet transfusion in the MIPLATE trial.

Keyphrases

sickle cell disease
phase iii
study protocol

electronic health record
cardiac surgery
clinical trial

big data
randomized controlled trial
acute kidney injury

open label
machine learning
red blood cell